Literature DB >> 20149445

The use of high-hydrostatic pressure treatment to decellularize blood vessels.

Seiichi Funamoto1, Kwangwoo Nam, Tsuyoshi Kimura, Ayako Murakoshi, Yoshihide Hashimoto, Kazuo Niwaya, Soichiro Kitamura, Toshiya Fujisato, Akio Kishida.   

Abstract

A decellularization method using high-hydrostatic pressure (HHP) technology (>600MPa) is described. The HHP disrupts the cells inside the tissue. The cell debris can be eliminated with a simple washing process, producing clean, decellularized tissue. In this study, porcine aortic blood vessel was decellularized by HHP. The mechanical properties and in vivo performance of the decellularized tissue were evaluated. Mechanical properties of the decellularized tissue were not altered by the HHP treatment. Reduced inflammation of the decellularized tissue was confirmed by xenogenic transplant experimentation. An allogenic transplantation study showed that decellularized blood vessel endured the arterial blood pressure, and there was no clot formation on the luminal surface. In addition, cellular infiltration into the vessel wall was observed 4 weeks after implantation, suggesting that HHP treatments could be applied widely as a high-quality decellularization method. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149445     DOI: 10.1016/j.biomaterials.2010.01.073

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  40 in total

1.  Hepatocyte culture in autologous decellularized spleen matrix.

Authors:  Rui Gao; Wanquan Wu; Junxi Xiang; Yi Lv; Xinglong Zheng; Qian Chen; Haohua Wang; Bo Wang; Zhengwen Liu; Feng Ma
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

2.  Effect of treatment temperature on collagen structures of the decellularized carotid artery using high hydrostatic pressure.

Authors:  Jun Negishi; Seiichi Funamoto; Tsuyoshi Kimura; Kwangoo Nam; Tetsuya Higami; Akio Kishida
Journal:  J Artif Organs       Date:  2011-05-11       Impact factor: 1.731

3.  Micro-CT evaluation of high pressure-decellularized cardiovascular tissues transplanted in rat subcutaneous accelerated-calcification model.

Authors:  Atsushi Mahara; Mitsuru Sago; Haruka Yamaguchi; Tomo Ehashi; Kenji Minatoya; Hiroshi Tanaka; Takeshi Nakatani; Toshiyuki Moritan; Toshiya Fujisato; Tetsuji Yamaoka
Journal:  J Artif Organs       Date:  2014-12-04       Impact factor: 1.731

4.  Xenogeneic Decellularized Scaffold: A Novel Platform for Ovary Regeneration.

Authors:  Wen-Yue Liu; Shi-Gang Lin; Ru-Yi Zhuo; Yuan-Yuan Xie; Wei Pan; Xian-Feng Lin; Fei-Xia Shen
Journal:  Tissue Eng Part C Methods       Date:  2017-01-10       Impact factor: 3.056

Review 5.  Assembly of cells and vesicles for organ engineering.

Authors:  Tetsushi Taguchi
Journal:  Sci Technol Adv Mater       Date:  2011-10-10       Impact factor: 8.090

6.  Decellularization of porcine carotid by the recipient's serum and evaluation of its biocompatibility using a rat autograft model.

Authors:  Naoaki Ishino; Toshia Fujisato
Journal:  J Artif Organs       Date:  2015-01-31       Impact factor: 1.731

7.  Decellularized Lymph Nodes as Scaffolds for Tissue Engineered Lymph Nodes.

Authors:  Daniel A Cuzzone; Nicholas J Albano; Seth Z Aschen; Swapna Ghanta; Babak J Mehrara
Journal:  Lymphat Res Biol       Date:  2014-08-21       Impact factor: 2.589

Review 8.  Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications.

Authors:  Manuela Lopera Higuita; Leigh G Griffiths
Journal:  Tissue Eng Part B Rev       Date:  2019-11-27       Impact factor: 6.389

Review 9.  Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization.

Authors:  Maelene L Wong; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2014-01-31       Impact factor: 8.947

Review 10.  An overview of tissue and whole organ decellularization processes.

Authors:  Peter M Crapo; Thomas W Gilbert; Stephen F Badylak
Journal:  Biomaterials       Date:  2011-02-05       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.